Alzheimer's Disease Clinical Trials near Houston, TX
20 studies for Alzheimer's Disease are recruiting at 27 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Alzheimer's Disease trials in the US or all trials near Houston.
Recruiting now
Alzheimer's Disease studies enrolling near Houston
- ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
- Phase 2/3
- Ages 55 to 95 years
- Sex: All
Nearest sites: Clinical Trial Network LLC (Houston, TX); Kaleidoscope Clinical Research (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 6 sites within 50 mi
- Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest sites: Clinical Trial Network - 7080 Southwest Fwy (Houston, TX); Horizon Clinical Research: Gill Neuroscience (Cypress, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352
- Phase 3
- Ages 50 to 90 years
- Sex: All
Nearest sites: Re:Cognition Health - Houston (Houston, TX); Mt.Olympus Medical Research (Katy, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
NCT05511363
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest site: Clinical Trial Network - 7080 Southwest Fwy (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200
- Observational
- Ages 18 to 90 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Houston Methodist Research Institute (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
NCT06584357
- Observational
- Ages 60 to 90 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Re:Cognition Health (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Stem Cell Therapy for Early Alzheimer's Disease
NCT06775964
- Phase 1/2
- Ages 60 to 80 years
- Sex: All
Nearest site: The University of Texas Health Science Center at Houston (UTHealth) (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709
- Phase 2
- Ages 50 to 85 years
- Sex: All
Nearest site: GSK Investigational Site (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Epidemiology and Biomarker Study in Alzheimer's Disease
NCT07142954
- Phase 3
- Ages 55 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Care Access - Houston (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Phosphorylated Tau Levels in Donated Blood
NCT07157839
- Observational
- Ages Any age
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Texas Health Science Center at Houston (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595
- Phase 2
- Ages 55 to 85 years
- Sex: All
Nearest site: The University of Texas Health Science Center at Houston (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582
- Phase 3
- Ages 55 years and older
- Sex: All
Nearest site: The University of Texas Health Science Center at Houston (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
NCT07651319
- Phase 1/2
- Ages 50 to 86 years
- Sex: All
Nearest site: Houston Methodist Research Institute (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
NCT07667478
- Interventional
- Ages 55 to 90 years
- Sex: All
Nearest site: Baylor College of Medicine (Houston, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
NCT06126224
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest site: Local Institution - 1106 (Cypress, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
NCT06540833
- Phase 2
- Ages 55 years and older
- Sex: All
Nearest site: Horizon Clinical Research Group (Cypress, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
NCT06808984
- Phase 2
- Ages 55 to 90 years
- Sex: All
Nearest site: Horizon Clinical Research Center - Houston (Cypress, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest site: Horizon Clinical Research Center - Houston (Cypress, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494
- Phase 2
- Ages 50 to 85 years
- Sex: All
Nearest site: Horizon Clinical Research Center - Houston ( Site 1026) (Cypress, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT07633470
- Phase 4
- Ages 50 years and older
- Sex: All
Nearest site: Mt. Olympus Medical Research, Llc - Katy (Katy, TX)
- Distance to nearest recruiting site
- ~28 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Alzheimer's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.